. Rifampicin inhibits alpha-synuclein fibrillation and disaggregates fibrils. Chem Biol. 2004 Nov;11(11):1513-21. PubMed.

Recommends

Please login to recommend the paper.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

  1. Rifampicin has real potential in treating Parkinson's patients. I believe failure to follow up on this lead would do a grave disservice to all those now sufferiing with PD.

This paper appears in the following:

News

  1. Rifampicin for Parkinson Disease?